Table 3 Expression level of p53, TNF-α, IL-6 and Presenillin-1 in the brain tissue of the negative control group and groups administered acrylamide or/and TiO2NPs.

From: Estimation of genotoxicity, apoptosis and oxidative stress induction by TiO2 nanoparticles and acrylamide subacute oral coadministration in mice

Group

Treatment (dose mg/kg)

P53

TNF-α

IL-6

Presenillin-1

I

Negative control

(deionized water)

1.00 ± 0.00a

1.00 ± 0.00a

1.00 ± 0.00a

1.00 ± 0.00a

II

Acrylamide (3 mg/kg)

4.23 ± 0.28b

2.71 ± 0.14b

3.35 ± 0.11b

2.32 ± 0.07b

III

TiO2-NPs (5 mg/kg)

2.12 ± 0.18c

2.06 ± 0.15c

2.36 ± 0.07c

1.94 ± 0.16c

IV

Acrylamide + TiO2-NPs

4.75 ± 0.24d

3.59 ± 0.17d

5.26 ± 0.23d

2.22 ± 0.10b

One Way Analysis of Variance

F = 214.55

P < 0.001

F = 215.37

P < 0.001

F = 541.18 P < 0.001

F = 105.51 p < 0.001

  1. Results are expressed as mean ± SD. Results were analyzed using one-way analysis of variance followed by Duncan’s test to test the similarity between the control and three treated groups. Means with different letters indicates statistical significant difference between the compared groups in the same column.